Skip to main navigation Skip to search Skip to main content

A new neolignan and lignans from the stems of Lindera obtusiloba Blume and their anti-allergic inflammatory effects

  • Hyun Gyu Choi
  • , Yeon Ho Choi
  • , Ji Hyang Kim
  • , Hui Hun Kim
  • , Sang Hyun Kim
  • , Jeong Ah Kim
  • , Sang Myung Lee
  • , Minkyun Na
  • , Seung Ho Lee
  • Yeungnam University
  • Kyungpook National University
  • Korea Ginseng Corporation
  • Chungnam National University

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

A new neolignan, linderin A (1), together with six known lignans, (+)-xanthoxyol (2), pluviatilol (3), actiforin (4), (+)-syringaresinol (5), (+)-(7S,8R,8′R)-acuminatolide (6), and (+)-9′-O-trans-feruloyl-5, 5′-dimethoxylariciresinol (7) were isolated from the stems of Lindera obtusiloba Blume (Lauraceae). Their chemical structures were elucidated by a combination of spectroscopic analysis and chemical reaction, and the absolute configuration of 1 was determined by Mosher's esterification. The effect of compounds 1-7 on tumor necrosis factor (TNF)-α, interleukin(IL)-6, and their inhibitory activity of histamine release were examined using human mast cells. Among the lignans tested, compounds 1, 3, 4, 6, and 7 inhibited release of histamine from mast cells. Especially, compounds 1 and 4 suppressed the gene expressions of pro-inflammatory cytokines, TNF-α, and IL-6 in human mast cells. Our findings suggest that the lignan constituents in L. obtusiloba may contribute to its anti-allergic inflammatory effects.

Original languageEnglish
Pages (from-to)467-472
Number of pages6
JournalArchives of Pharmacal Research
Volume37
Issue number4
DOIs
StatePublished - Apr 2014

Keywords

  • Anti-allergic effect
  • Keywords:: Lindera obtusiloba
  • Lignan
  • Linderin A

Fingerprint

Dive into the research topics of 'A new neolignan and lignans from the stems of Lindera obtusiloba Blume and their anti-allergic inflammatory effects'. Together they form a unique fingerprint.

Cite this